Early Genetic Identification of Obesity
WEGIO
Whole Genetic Approach in Early Genetic Identification of Obesity (WEGIO)
1 other identifier
observational
1,000
1 country
37
Brief Summary
TITLE: Whole genetic approach in Early Genetic Identification of Obesity (WEGIO) DESIGN: Multicenter epidemiological study STUDY POPULATION: Participants at risk for a syndromic or a monogenic genetic obesity, incl. participants clinically diagnosed with Bardet-Biedl-Syndrome (BBS) NUMBER OF PARTICIPANTS: 1000 for initial genetic sequencing and app. 40 for the follow-up documentation COORDINATING INVESTIGATOR: Prof. Dr. Arndt Rolfs
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
Typical duration for all trials
37 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 24, 2024
CompletedFirst Submitted
Initial submission to the registry
January 25, 2024
CompletedFirst Posted
Study publicly available on registry
February 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
ExpectedSeptember 29, 2025
February 1, 2025
2.1 years
January 25, 2024
September 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
BBS prevalence
To investigate the prevalence of BBS in patients suspected to a genetic obesity
2 years
Secondary Outcomes (1)
Phenotypic and genetic characterization
2 years
Study Arms (1)
Participants suspected to genetic obesity
Participants suspected to genetic obesity
Interventions
blood collection
Eligibility Criteria
Participants at risk for a syndromic or a monogenic genetic obesity, incl. participants clinically diagnosed with Bardet-Biedl-Syndrome (BBS)
You may qualify if:
- Informed consent is obtained from the participant/parent/legal guardian
- The participant is 2 years of age or older
- For a participant between 2 and 18 years of age:
- The participant has and had a body weight more than 97th percentile before the age of 6
- The participant has one or more of the following symptoms:
- rod/cone dystrophy, renal abnormalities, ataxia, syndactyly, polydactyly, brachydactyly, hyperphagia, cognitive impairment, speech delay, hypogonadism
- For a participant who is 18 years of age or older:
- The participant has BMI ≥ 30 kg/m2
- The participant had a body weight more than 97th percentile before the age of 6 years
- The participant has rod/cone dystrophy
- The participant is 2 or more years of age, is clinically diagnosed with Bardet-Biedl-Syndrome (BBS) or is a sibling of an individual diagnosed with BBS via the WEGIO study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (37)
Universitätsklinikum Aachen (RWTH)
Aachen, 52074, Germany
KJF Klinik Josefinum
Augsburg, 86154, Germany
Universitätsklinikum Augsburg - Klinik für Kinder- und Jugendmedizin
Augsburg, 86156, Germany
Universitätsklinikum Freiburg
Bad Krozingen, 79189, Germany
Klinikum Bielefeld Mitte
Bielefeld, 33604, Germany
Universitätsklinikum Bonn
Bonn, 53127, Germany
Praxis für Endokrinologie Dr. Daniel Pfaff
Bückeburg, 31675, Germany
Cellitinnen-Krankenkaus St. Franziskus
Cologne, 50825, Germany
Universitätsmedizin Essen
Essen, 45147, Germany
Klinikum Frankfurt (Oder)
Frankfurt (Oder), 15236, Germany
SRH Wald-Klinikum Gera
Gera, 07548, Germany
Universitätsmedizin Göttingen - Klinik für Kinder- und Jugendmedizin
Göttingen, 37075, Germany
WolfartKlinik
Gräfelfing, 82166, Germany
Universitätsmedizin Greifswald - Klinik und Poliklinik für Innere Medizin A
Greifswald, 17475, Germany
Katholisches Kinderkrankenhaus WILHELMSTIFT
Hamburg, 22149, Germany
Kinder- und Jugendkrankenhaus Auf der Bult
Hanover, 30173, Germany
Hormonzentrum Heidelberg
Heidelberg, 69115, Germany
Kinder- und Jugendarztpraxis Nebras Mohammad
Iserlohn, 58636, Germany
Universitätsklinikum Jena
Jena, 07747, Germany
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Kiel, 24105, Germany
Sozialpädiatrisches Zentrum Leipzig
Leipzig, 04129, Germany
Universitätsmedizin Mannheim - Augenklinik
Mannheim, 68167, Germany
Städtische Kliniken Mönchengladbach - Elisabeth-Krankenhaus Rheydt
Mönchengladbach, 41239, Germany
Kinder- und Jugendarztpraxis Sulaiman Al Sawaf
Nettetal, 41334, Germany
Dietrich-Bonhoeffer-Klinikum
Neubrandenburg, 17036, Germany
Hausarztpraxis Rahman & Detho
Obertshausen, 63179, Germany
Sana Klinikum Offenbach
Offenbach, 63069, Germany
Kinderärzte am Leo
Pforzheim, 75172, Germany
Klinikum Ernst von Bergmann
Potsdam, 14467, Germany
Elblandklinikum Riesa
Riesa, 01589, Germany
GPR Klinikum Rüsselsheim
Rüsselsheim am Main, 65428, Germany
Kinder- und Jugendpraxis Dogan
Stuttgart, 70178, Germany
SRH Zentralklinikum Suhl GmbH
Suhl, 98527, Germany
Praxis für Kinder- und Jugendmedizin Dr. med. Tabea Tippelt
Velbert, 42551, Germany
Dreifaltigkeits-Krankenhaus Wesseling
Wesseling, 50389, Germany
Praxis für Kinder- und Jugendmedizin Seyfullah Gökce
Wiesbaden, 65185, Germany
Universitätsklinikum Würzburg - Medizinische Klinik und Poliklinik I
Würzburg, 97080, Germany
Biospecimen
blood samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Arndt Rolfs, PhD, MD
Rolfs Consulting und Verwaltungs-GmbH (RCV)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2024
First Posted
February 2, 2024
Study Start
January 24, 2024
Primary Completion
March 1, 2026
Study Completion (Estimated)
March 1, 2027
Last Updated
September 29, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share